Abstract:
A hybrid service terminal for use in a passive fiber optic network comprises a plurality of optical fiber connectors, each coupled to a respective optical fiber for receiving downstream optical frames from an Optical Line Terminal (OLT); a plurality of hybrid fiber/copper connectors, each of the hybrid fiber/copper connectors coupled to a respective one of the plurality of optical fiber connectors; and a plurality of electrical connectors configured to receive electrical signals from a multi-line converter module over a respective one of a plurality of electrical conductors. One of the plurality of hybrid fiber/copper connectors is configured to provide the downstream optical frames to the multi-line converter module for conversion to the electrical signals. Each of the plurality of electrical connectors is coupled to a respective one of the plurality of hybrid fiber/copper connectors for providing the electrical signals over a respective metallic drop cable coupled to a respective network terminal at a corresponding customer premise.
Abstract:
A pharmaceutical dosage form which comprises diphenhydramine and/or a pharmaceutically acceptable salt thereof and at least one second drug. The dosage form provides a plasma concentration within the therapeutic range of the at least one second drug over a period which is coextensive with a substantial part of the period over which the dosage form provides a plasma concentration within the therapeutic range of diphenhydramine or salt thereof. This Abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
Abstract:
The present invention discloses a method and device for dispersing powders and, in particular, to a method of dispersing inhaling powders in which a powder is positioned in a passage wherein the passage has one or more exits, one or more inlets and one or more obstructions to block the movement or to contain the powder within the device before use, whereupon a breaching pressure differential between the one or more exits and the one or more inlets of the passage is applied to breach the one or more obstructions so as to generate a flow through the passage which fully or partially aerosolizes the powder by means of the generated flow thus releasing a fully or partially aerosolized powder from the device.
Abstract:
An improved HVAC system is provided for the delivery of a temperature controlled air supply via one or more air curtains provided at windows, doors and walls. The air curtains create a double layer of insulation over the surface of a window, door or wall. The invention provides for the use of the temperature controlled air flow from the air curtain to directly affect the interior room temperature. The invention provides an improved system for continuous cleaning the recycled air through the use of a wet electrostatic precipitator in the HVAC air flow, as well as providing a higher speed mode for the air curtain to prevent the inflow of particles and contaminants from outside of the building, when windows or doors are open. The invention may be installed on existing construction, or incorporated as part of new construction.
Abstract:
A pharmaceutical dosage form which comprises two or more different hyoscyamine formulations, at least one of the formulations being an immediate release hyoscyamine formulation and at least one other one being a controlled release hyoscyamine formulation. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
Abstract:
Embodiments are directed to portable infusion devices, systems, and methods of using the same for dispensing materials. In some cases, the devices, systems and methods may be used for infusing a material such as medicament, e.g., insulin, into a body in need thereof.
Abstract:
This application describes emulsion formulations containing neutral phospholipids for delivering RNAi, anti-miRNA, or aptamer agents in vivo. The application also relates to methods of making the formulations, and uses of the formulations as delivery agents.
Abstract:
This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.
Abstract:
Described embodiments provide a network processor having a plurality of processing modules coupled to a system cache and a shared memory. A memory manager allocates blocks of the shared memory to a requesting one of the processing modules. The allocated blocks store data corresponding to packets received by the network processor. The memory manager maintains a reference count for each allocated memory block indicating a number of processing modules accessing the block. One of the processing modules reads the data stored in the allocated memory blocks, stores the read data to corresponding entries of the system cache and operates on the data stored in the system cache. Upon completion of operation on the data, the processing module requests to decrement the reference count of each memory block. Based on the reference count, the memory manager invalidates the entries of the system cache and deallocates the memory blocks.
Abstract:
Non-sequential monitoring of battery cells in battery monitoring systems, and related components, systems, and methods are disclosed. In one embodiment, a battery monitoring system control unit is provided. The battery monitoring system control unit is configured to control battery monitoring devices. Each battery monitoring device is configured to be coupled to a subset of battery cells electrically connected in series in a sequential order to form a battery. The battery monitoring system control unit is further configured to instruct the battery monitoring devices to test an ohmic value of each battery cell of the battery cells of the battery in a non-sequential order. In this manner, heat generated in the battery monitoring devices from the testing may be more effectively dissipated, which can also allow for the battery monitoring devices to be employed in higher operating temperature environments.